Vascular Graft Solutions (VGS) was established in 2009, with the aim of improving the results of
coronary revascularization procedures by developing innovative technologies.
Using a research-driven approach, we have effectively addressed difficult and complex challenges in coronary revascularization, particularly vein graft disease in CABG surgery. These unmet clinical needs are frequently encountered and have a considerable impact on patients’ quality of life and healthcare system expenses.
Vascular Graft Solutions’ portfolio of products is increasingly gaining acceptance as a standard of care in cardiac surgery.
Our Management Team
M.D., Founder & Active Chairman
Eyal is a serial MedTech entrepreneur and co-founder of multiple medical device companies. Eyal founded VGS in 2009 and served as CEO until October…
VP Clinical & Regulatory Affairs
Orit is a veteran of the Israeli medical device industry with 25+ years of experience, fulfilling senior management roles in clinical, regulatory, research…
VP Engineering & Manufacturing
Liad in an experienced executive with more than 10 years’ experience in R&D, operations and manufacturing. Starting as R&D project manager at VGS in 2009…
Dana serves as legal counsel of VGS since its inception. With extensive experience of over 25 years in advising and supporting start-up companies…
VP Marketing & Sales
Elad joined VGS in 2018 and has held diverse roles across different geographical locations. With an extensive experience in marketing and sales across various positions…
VP Quality Assurance
Rachel Joined VGS in 2012, and since, was responsible of managing the Quality Assurance processes in the company. With an extensive knowledge in the field…